134 related articles for article (PubMed ID: 30197334)
1. Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma.
Chauhan A; Bhattacharyya S; Ojha R; Mandal AK; Singh SK
J Cancer Res Ther; 2018; 14(5):977-982. PubMed ID: 30197334
[TBL] [Abstract][Full Text] [Related]
2. Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma.
Chen Z; Li Z; Li C; Li B; Wang H; Nong D; Li X; Huang G; Lin J; Li W
BMC Cancer; 2022 Dec; 22(1):1277. PubMed ID: 36474188
[TBL] [Abstract][Full Text] [Related]
3. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
4. [Speckle-type POZ protein up-regulates c-Jun protein expression and promotes proliferation and invasion of renal carcinoma cells].
Wu L; Yu K; Cue Y; Zhu X; Yang Z; Ma J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):447-452. PubMed ID: 33849838
[TBL] [Abstract][Full Text] [Related]
5. SPOP, ZEB-1 and E-cadherin expression in clear cell renal cell carcinoma (cc-RCC): Clinicopathological and prognostic significance.
Harb OA; Elfeky MA; El Shafaay BS; Taha HF; Osman G; Harera IS; Gertallah LM; Abdelmonem DM; Embaby A
Pathophysiology; 2018 Dec; 25(4):335-345. PubMed ID: 29801752
[TBL] [Abstract][Full Text] [Related]
6. The E2F1-miR-520/372/373-SPOP Axis Modulates Progression of Renal Carcinoma.
Ding M; Lu X; Wang C; Zhao Q; Ge J; Xia Q; Wang J; Zen K; Zhang CY; Zhang C
Cancer Res; 2018 Dec; 78(24):6771-6784. PubMed ID: 30348808
[TBL] [Abstract][Full Text] [Related]
7. MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma.
Raina P; Singh SK; Goswami AK; Kashyap MK; Khullar M; Sharma SK; Barwal KC
Mol Cell Biochem; 2022 Feb; 477(2):333-343. PubMed ID: 34716861
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.
Giribaldi G; Barbero G; Mandili G; Daniele L; Khadjavi A; Notarpietro A; Ulliers D; Prato M; Minero VG; Battaglia A; Allasia M; Bosio A; Sapino A; Gontero P; Frea B; Fontana D; Destefanis P
J Proteomics; 2013 Oct; 91():385-92. PubMed ID: 23916412
[TBL] [Abstract][Full Text] [Related]
11. The association of speckle-type POZ protein with lymph node metastasis and prognosis in cancer patients: A meta-analysis.
Cheng F; Zeng C; Zeng L; Wu C; Chen Y
Medicine (Baltimore); 2019 Oct; 98(40):e17439. PubMed ID: 31577764
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of the SPOP gene is associated with poor prognosis in glioma.
Ding D; Song T; Jun W; Tan Z; Fang J
Int J Oncol; 2015 Jan; 46(1):333-41. PubMed ID: 25351530
[TBL] [Abstract][Full Text] [Related]
13. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
15. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK
Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952
[TBL] [Abstract][Full Text] [Related]
16. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
[TBL] [Abstract][Full Text] [Related]
18. Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma.
Iliev R; Fedorko M; Machackova T; Mlcochova H; Svoboda M; Pacik D; Dolezel J; Stanik M; Slaby O
Anticancer Res; 2016 Dec; 36(12):6419-6423. PubMed ID: 27919963
[TBL] [Abstract][Full Text] [Related]
19. Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.
Huang Y; Tan N; Jia D; Jing Y; Wang Q; Li Z; Zhang J; Liu L; Li J; Chen Z; He X
Tumour Biol; 2015 Dec; 36(12):9753-61. PubMed ID: 26156804
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of SPOP in Cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
